R229Q Polymorphism of NPHS2 Gene in Patients With Late-Onset Steroid-Resistance Nephrotic Syndrome: a Preliminary Study

Authors

  • Nikou Fotouhi Chronic Kidney Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Mohammadreza Ardalan Chronic Kidney Disease Research Center and Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Mortaza Jabbarpour Bonyadi Center of Excellence for Biodiversity, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran Author
  • Reza Abdolmohammadi Center of Excellence for Biodiversity, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran Author
  • Amir Kamalifar Chronic Kidney Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran Author
  • Hamid Nasri Department of Nephrology, Isfahan University of Medical Sciences, Isfahan, Iran Author
  • Behzad Einollahi Nephrology and Urology Research Center, Baqiyatallah University of Medical Sciences, Baqiyatallah Hospital, Tehran, Iran Author

Abstract

Introduction. Depending on the response to standard steroid therapy, nephrotic syndrome it is classified to steroid-sensitive and steroid-resistant nephrotic syndrome (SRNS). Mutations in several genes including NPHS2 have been implicated in SRNS. Gene R229Q polymorphism (p.R229Q) of NPHS2 is associated with adolescent- or adult-onset SRNS in European and South American populations. We investigated this polymorphism among a group of Iranian-Azeri patients with primary SRNS.

Materials and Methods. All participants had the primary late-onset form of focal
segmental glomerulosclerosis (FSGS) and their clinical feature was steroid unresponsiveness. They were compared with a group of age- and sex-matched individuals without any renal disease for NPHS2 gene as controls. The R229Q polymorphism (p.R229Q) was investigated in the case and control groups.

Results. A total of 25 patients (mean age, 26.6 ± 8.0 years) with primary FSGS and 35 controls (mean age, 26.0 ± 8.7 years) were studied. Serum creatinine of patients and their 24-hour protein excretion at the time of study were 2.4 ± 1.94 mg/dL and 2830 ± 981 mg/dL, respectively. Molecular study showed no p.R229Q polymorphism, neither in patients nor in controls.

Conclusions. In this preliminary study, we showed that NPHS2 gene p.R229Q polymorphism does not present in Iranian-Azeri population with SRNS. Larger studies are needed to confirm our results and other mutated genes should also be considered in these patients.

Downloads

Download data is not yet available.

Downloads

Published

2013-09-27

Issue

Section

ORIGINAL | Kidney Diseases

How to Cite

R229Q Polymorphism of NPHS2 Gene in Patients With Late-Onset Steroid-Resistance Nephrotic Syndrome: a Preliminary Study. (2013). Iranian Journal of Kidney Diseases, 7(5), 399-403. https://www.ijkd.org/index.php/ijkd/article/view/1053

Most read articles by the same author(s)

<< < 2 3 4 5 6 7